🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the safety and efficacy of 3 doses of bimatoprost ...
Status
Completed
Location
Multiple Locations
Start Date
2011-06
Trial ID
NCT01325337
The purpose of this study was to assess the safety and describe the steady-...
Status
Completed
Location
Multiple Locations
Start Date
2013-01
Trial ID
NCT01658839
Treatments Being Tested
The Purpose of this study is to assess the relative bioavailability, dose p...
Status
Terminated
Location
Clinical Pharmacology of Miami, Llc
Start Date
2019-10-25
Trial ID
NCT04131556
Treatments Being Tested
All enrolled participants will be randomized to 3 cohorts with 8 participan...
Status
Completed
Location
Universität Basel Departement Klinische Forschung Ambulantes Studienzentrum
Start Date
2023-03-28
Trial ID
NCT05848453
Treatments Being Tested
The study will consist of a screening period, 3 treatment periods and a pos...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-09-20
Trial ID
NCT00536679
Treatments Being Tested
Our hypothesis is to test that 1) The safety and efficacy of Nano+ DES in p...
Status
Unknown
Location
UZ Virga Jesse Ziekenhuis
Start Date
2013-07
Trial ID
NCT01925027
Treatments Being Tested
The primary purpose of the study is to determine if a new sustained-release...
Status
Completed
Location
Urology Centers of Alabama
Start Date
2003-03
Trial ID
NCT00056654
Treatments Being Tested
This is a single center study to evaluate the pharmacokinetics of ARMS-I a ...
Status
Withdrawn
Location
ProMedica Health System
Start Date
2017-01
Trial ID
NCT03026205
Treatments Being Tested
The purpose of this study is to compare the safety, pharmacokinetics, and p...
Status
Completed
Location
Quinta-Analytica s.r.o.
Start Date
2025-06-15
Trial ID
NCT07323680
Treatments Being Tested
A Phase 1, Open-Label Study to Investigate the Safety, Tolerability, and Ph...
Status
Completed
Location
Research Site
Start Date
2025-06-20
Trial ID
NCT06868082
Treatments Being Tested